3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats
Journal of Pharmacy and Pharmacology · 01.06.2024 · 76 (6) · 616-626
DOI: 10.1093/jpp/rgae043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.06.2024. Verfasst von Arvind Bagde und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, United States. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Cannabidiol, Needles, Drug Delivery Systems. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NIH HHS, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
Objective
The objective of the present study was to enhance the bioavailability of cannabidiol (CBD) using 3D Digital Light Processing (DLP)-printed microneedle (MN) transdermal drug delivery system.
Methods
CBD MN patch was fabricated and optimized using 3D DLP printing using CBD (8% w/v), Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) (0.49% w/v), distilled water (20% w/v), and poly (ethylene glycol) dimethacrylate 550 (PEGDAMA 550) (up to 100% w/v). CBD MNs were characterized for their morphology, mechanical strength, in vitro release study, ex vivo permeation study, and in vivo pharmacokinetic (PK) profile. Key findings Microscopic images showed that sharp CBD MNs with a height of ~800 μm, base diameter of ~250 μm, and tip with a radius of curvature (RoC) of ~15 μm were successfully printed using optimized printing parameters. Mechanical strength studies showed no significant deformation in the morphology of CBD MNs even after applying 0.5N/needle force. Ex vivo permeation study showed significant (P < .0001) permeation of CBD in the receiving media as compared to CBD patch (control). In vivo PK study showed significantly (P < .05) enhanced bioavailability in the case of CBD MN patch as compared to CBD subcutaneous inj. (control).
Conclusion
Overall, systemic absorption of CBD was significantly enhanced using 3D-printed MN drug delivery system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, United States.
- PCOM School of Pharmacy, Philadelphia College of Osteopathic Medicine (PCOM), Philadelphia, PA 19131, United States.
ORCID-Profile: Mandip Singh
Förderung
- NIMHD NIH HHS
- NIH HHS
- National Institute on Minority Health and Health Disparities
- National Institutes of Health
Zitieren
APA
Bagde, A., Mosley-Kellum, K., Spencer, S., & Singh, M. (2024). 3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats. Journal of Pharmacy and Pharmacology, 76(6), 616-626. https://doi.org/10.1093/jpp/rgae043
Vancouver
Bagde A, Mosley-Kellum K, Spencer S, Singh M. 3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats. Journal of Pharmacy and Pharmacology. 2024;76(6):616-626. doi:10.1093/jpp/rgae043
BibTeX
@article{Bagde2024,
author = {Bagde, Arvind and Mosley-Kellum, Keb and Spencer, Shawn and Singh, Mandip},
title = {3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
volume = {76},
number = {6},
pages = {616--626},
doi = {10.1093/jpp/rgae043}
}
EUVIMED